BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2018
View Archived Issues
Expression of semaphorins 4D and 3A is regulated by adenosine A2A receptor in bone homeostasis
Read More
Bio-Thera Solutions initiates phase I study of tocilizumab biosimilar BAT-1806
Read More
Foresee completes phase I study of ALDH2 activator FP-045
Read More
Ignoring mutation and targeting inflammation
Read More
Myelin restoration: hold the fat
Read More
Freezing-induced dominant conformation facilitates peptide ligation during IFN-epsilon synthesis
Read More
FGF21 gene transfer by adeno-associated viral vectors as therapy for obesity and insulin resistance
Read More
11Leu allele of TLR7 gene a protective factor of fibrosis progression in HIV/HCV coinfected patients
Read More
Influenza RNA-directed RNA polymerase inhibitors patented by Sunshine Lake Pharma
Read More
CV6 Therapeutics presents deoxyuridine nucleotidohydrolase inhibitors
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical identify A2A receptor antagonists
Read More
BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group
Read More
PKR targeting benefits spatial memory and brain lesions in AD model
Read More
New compound inhibits Wnt, activates p53, targets CRC
Read More
Tonix to stop HONOR study of Tonmya for PTSD due to inadequate separation from placebo at week 12
Read More
FDA approves Perseris once-monthly subcutaneous injection for schizophrenia
Read More
FDA issues complete response letter for Insys' buprenorphine sublingual spray
Read More
Promising phase I results with KY-1005 pave way for phase II evaluation in atopic dermatitis
Read More
European Commission approves adalimumab biosimilar Hyrimoz
Read More
CRISPR-Cas9 DeltaFosB knockdown provides model of overeating
Read More
Researchers find SCRN1 presence in early neurofibrillary tangles in AD pathology
Read More
WP-1066 begins first-in-human study in recurrent malignant glioma and brain metastasis from melanoma
Read More
Daiichi Sankyo and Glycotope sign licensing agreement for gatipotuzumab-based ADC
Read More
LIDDS reports preclinical findings with NanoZolid-formulated STING agonist
Read More
Invectys begins phase II trial of INVAC-1 for high-risk CLL
Read More
